Trial intelligence / Profile preview

Double Umbilical Cord Blood Transplant in Hematologic Malignancies

NCT01015742Phase 3Unknown

Sponsor
Tehran University of Medical Sciences
Start
Nov 2009
Primary completion
Dec 2012
Modality
Hematopoietic Stem Cells
Countries
1
01

Overview

A Phase 3 trial of umbilical cord blood in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), sponsored by Tehran University of Medical Sciences. Status: unknown.

02

Drugs

umbilical cord blood
03

Conditions

acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic myeloid leukemia (CML)

Beyond the preview

Go deeper on NCT01015742.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01015742.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call